Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.

Atherosclerosis - 1 Apr 1999

Gaw A, Docherty G, Brown E A, Ford I

Abstract excerpt

An elevated plasma lipoprotein(a) (Lp(a)) concentration is an independent risk factor for coronary heart disease (CHD). Plasma Lp(a) levels are believed to be predominantly controlled by the APO(a) gene, which encodes the apo(a) glycoprotein moiety of the Lp(a) particle. However, other parameters in the lipoprotein profile as well as co-existing disease states or personal traits have been proposed as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to Apolipoproteins A
Share to Coronary Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Incidence

Share to Lipoprotein(a)

Share to Predictive Value of Tests

Share to Sampling Studies

Share to Scotland

Source

Identifiers

PMID: 10217375
DOI: 10.1016/s0021-9150(98)00305-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.PMID 10217375Read ↗

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.Semantic proximity Read ↗

Lp (a) levels and apo (a) phenotypes in urban black South African men.Semantic proximity Read ↗

Concentrations of the atherogenic Lp(a) are elevated in FH.Semantic proximity Read ↗

Use of the West of Scotland Coronary Prevention Study bio-bank to provide new insights into the control of plasma lipoprotein(a) concentrations.Semantic proximity Read ↗

Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.Semantic proximity Read ↗

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.Semantic proximity Read ↗

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring StudySemantic proximity Read ↗

Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.Semantic proximity Read ↗

Lipoprotein(a) determination and risk of cardiovascular disease in South African patients with familial hypercholesterolaemia.Semantic proximity Read ↗

Factors contributing to variation in lipoprotein (a) in Melbourne Anglo-Celtic population.Semantic proximity Read ↗

Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.Semantic proximity Read ↗

Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.